GlassScriptPhysician profile
Joseph Yurich
NPI 1013156728
$9,940.90
in general payments reported to CMS, 2019-2025
12 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $27.99 · 2021: $175 · 2022: $41.43 · 2023: $3,919 · 2024: $4,948 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,923 · Travel and Lodging: $1,351 · Food and Beverage: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,923.22 |
| Travel and Lodging | $1,351.31 |
| Food and Beverage | $1,229.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,186.11 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $164.89 | 2019-2024 | Phasix Mesh |
| Baxter Healthcare | $133.96 | 2025 | Tisseel |
| Organogenesis INC. | $91.43 | 2021-2024 | |
| Braintree Laboratories, INC. | $89.49 | 2020-2021 | |
| Osiris Therapeutics INC. | $60.92 | 2019 | |
| Stryker Corporation | $58.83 | 2021 | |
| Solventum Corporation | $55.45 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $33.93 | 2021-2022 | |
| Ethicon US, LLC | $24.68 | 2024 | Echelon Circular, Enseal |
| Merck Sharp & Dohme LLC | $21.72 | 2023 | Bridion |
| Kerecis Limited | $19.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Yurich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.